Inhibitory effects of erythromycin on wear debris-induced VEGF/Flt-1 gene production and osteolysis
- David C. MarkelAffiliated withDepartment of Orthopaedic Surgery, Wayne State University
- , Renwen ZhangAffiliated withStryker Company
- , Tong ShiAffiliated withDepartment of Biomedical Engineering, Wayne State University
- , Monica HawkinsAffiliated withStryker Company
- , Weiping RenAffiliated withDepartment of Biomedical Engineering, Wayne State University Email author
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
A highly vascularized and inflammatory periprosthetic tissue augments the progress of aseptic loosening, a major clinical problem after total joint replacement. The purpose of this study is to investigate the effect of erythromycin (EM) on ultra high molecular weight polyethylene (UHMWPE) particle-induced VEGF/VEGF receptor 1 (Flt-1) gene production and inflammatory osteolysis in a mouse model.
UHMWPE particles were introduced into established air pouches on BALB/c mice, followed by implantation of calvaria bone from syngeneic littermates. EM treatment started 2 weeks after bone implantation (5 mg/kg day, i.p. injection). Mice without drug treatment as well as mice injected with saline alone were included. Pouch tissues were harvested 2 weeks after bone implantation. Expression of VEGF, Flt-1, RANKL, IL-1, TNF and CD68 was measured by immunostain and RT-PCR, and implanted bone resorption was analyzed by micro-CT (μCT).
Exposure to UHMWPE induced pouch tissue inflammation, increase of VEGF/Flt-1 proteins, and increased bone resorption. EM treatment significantly improved UHMWPE particle-induced tissue inflammation, reduced VEGF/Flt-1 protein expression, and diminished the number of TRAP+ cells, as well as the implanted bone resorption.
This study demonstrated that EM inhibited VEGF and Flt-1 gene expression. The molecular mechanism of EM action on VEGF/Flt-1 signaling-mediated osteoclastogenesis warrants further investigation.
KeywordsVEGF Osteolysis Osteoclastogenesis Erythromycin Animal model Wear debris
- Inhibitory effects of erythromycin on wear debris-induced VEGF/Flt-1 gene production and osteolysis
- Online Date
- March 2009
- Print ISSN
- Online ISSN
- SP Birkhäuser Verlag Basel
- Additional Links
- Animal model
- Wear debris
- Industry Sectors
- Author Affiliations
- 1. Department of Orthopaedic Surgery, Wayne State University, Detroit, MI, 48201, USA
- 3. Stryker Company, Rutherford, NJ, 07070, USA
- 2. Department of Biomedical Engineering, Wayne State University, 818 W. Hancock, Detroit, MI, 48201, USA